515 results on '"adalimumab"'
Search Results
2. A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis (Horizon)
3. Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients with Tuberculosis MeNIngitis (TIMPANI)
4. A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis
5. Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis (SELECT- SWITCH)
6. Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial (SPEED)
7. A Study of Baricitinib in Participants With Rheumatoid Arthritis (RA-BRANCH)
8. A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA-BRIDGE)
9. Experimental Medicine Studies of the Brain in Patients With Rheumatoid Arthritis REALISE (REALISE)
10. A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis (BE OPTIMAL)
11. A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
12. De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease (FREE)
13. A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
14. A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab (KnaPsAck)
15. Efficacy of Biological Therapy in Pediatric Inflammatory Bowel Disease
16. A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate
17. The Anti-Freaze-F Study- 'Anti-TNF for Treatment of Frozen Shoulder - a Feasibility Study' (Anti-FreazeF)
18. IKBKB Gene Polymorphism (Single Nucleotide Polymorphism) (SNP) in Psoriatic and Psoriatic Arthritis Patients
19. Prevention of Postoperative Endoscopic Recurrence with Endoscopy-driven Versus Systematic Biological Therapy (SOPRANO-CD)
20. Observational Study, to Assess Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®) in IBD Patients in Real Life Setting (HYRISS)
21. Swiss Dermatology Network of Targeted Therapies (SDNTT) (SDNTT)
22. Effect of Proactive Therapeutic Drug Monitoring on Maintenance of Sustained Disease Control in Adults With Rheumatoid Arthritis on a Subcutaneous TNF Inhibitor: The Rheumatoid Arthritis Therapeutic DRUg Monitoring Trial (RA-DRUM) (RA-DRUM)
23. Effects of TNF Blockade on Human BPH/LUTS
24. Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration. (VEDIAN)
25. To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy Subjects
26. A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)
27. Comparison Between Infliximab and Adalimumab on Patients With Ulcerative Colitis
28. Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity
29. A Study to Evaluate 608 in Patients with Ankylosing Spondylitis (AS)
30. Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI
31. A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis
32. Study of the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of Netakimab in Children with Moderate to Severe Plaque Psoriasis (PLANETA-KIDS)
33. Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis
34. Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease
35. A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD) (SELECT - PsA 1)
36. Treatment Persistence of Biologics in Patients with PsA in Japan; Retrospective Cohort Study Using a Claims Database (FLYWAY)
37. Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
38. Application of N-of-1 Rheumatoid Arthritis
39. Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis
40. To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis
41. Filgotinib Effect on Proteomic Profile and Micro-RNA Expression in Patients With Active Rheumatoid Arthritis (RA) (FILRA)
42. CHronic Nonbacterial Osteomyelitis International Registry (CHOIR)
43. Therapeutic Drug Monitoring-baSed adalimuMab De-escalatiOn in nOn-infecTious cHronic Uveitis (SMOOTH)
44. Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic Study
45. A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease
46. Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis (RUBI)
47. A Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Participants Requiring High Dose Corticosteroids for Active Non-Infectious Intermediate, Posterior, or Pan-Uveitis
48. Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis
49. A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate (SELECT-COMPARE)
50. Therapeutic Monitoring of Infliximab and Adalimumab
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.